JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Shareholding for the Period Ended September 30, 2019
Jagsonpal Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In Compliance with Regulation 74 (5) of SEBl (Depositories and Participants) Regulations, 2018 we are forwarding herewith a copy of the Certificate received from M/s MCS Share Transfer Agent Limited, the Registrar and share Transfer Agent of the Company, for the quarter ended 30th September, 2019. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Appointment Of Company Secretary And Compliance Officer
Pursuant to the provisions of Regulation 30 and other applicable regulations of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 please note that Ms. Nandita Singh has been appointed as Company Secretary and Compliance Officer of the company with effect from 10th October, 2019, pursuant to Section 203 of the Companies Act 2013 and Regulation 6(1) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. Name : Nandita Singh Designation: Company Secretary & Compliance Officer Mobile No.: 9711421172 Tel No.: 011-46181100 (extn. 458, 457) Email id: nandita.singh@jagsonpal.com You are requested to please take on record our above said information as per requirement of Regulation 6 and Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 for your reference and please make necessary correction in the contact details of the Company on the website of BSE. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Retirement
Intimation of Retirement of Mr. R. K. Kapoor, Company Secretary and Compliance officer w.e.f. closure of the office hours of the Company. Jagsonpal Pharmaceuticals Ltd - 507789 - Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- R K KAPOORDesignation :- Company Secretary and Compliance Officer JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Jagsonpal Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Jagsonpal Pharmaceuticals Ltd - 507789 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Details of voting results at the 40th Annual General Meeting of the Company. Jagsonpal Pharmaceuticals Ltd - 507789 - Closure of Trading Window
In terms of SEBI (Prohibition of Insider Trading) Regulation, 2015 (as amended) and Company's Code of Conduct to regulate, monitor and report trading by designated persons & immediate relatives of Designated Persons and pursuant to the clarification issued by NSE vide Ref No: NSE/CML/2019/11 dated 02.04.2019 on the provisions of Clause 4 of the Schedule B of SEBI (Prohibition of Insider Trading) Regulation, 2015 (as amended), the Trading Window for dealing in securities of Jagsonpal Pharmaceuticals Limited ("the Company") shall remain closed for Designated Persons and their immediate relative(s) with effect from October 01, 2019 till the end of 48 hours after the declaration of financial results for the Quarter ended 30th September, 2019. Jagsonpal Pharmaceuticals Ltd - 507789 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceeding of the 40th Annual General Meeting held on 30th September, 2019. Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 read with Para A of Schedule III of SEE] (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the following documents as required under Section 124 of the Companies Act, 2013 read with Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund] Rules, 2016:- 1. Copy of Circular Letter sent to shareholders. 2. Copy of Newspaper Advertisement published on September 06, 2019, in Business Standard (English) and Business Standard (Hindi).